MedTrace Logo

Interindividual Variation in Excretion of Curcumin

NCT03746158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-12-17

No results posted yet for this study

Summary

The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.

Conditions

  • Metabolites
  • Gut Microbiota

Interventions

DIETARY_SUPPLEMENT

curcumin

subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).

Sponsors & Collaborators

  • University of Massachusetts, Amherst

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-03-01
Completion
2019-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03746158 on ClinicalTrials.gov